Perspectives in Medicinal Chemistry
Synopsis: An open access, peer reviewed electronic journal that covers drug design in the form of commentaries and reviews which do not require disclosure of proprietary information.
Indexing: Pubmed, Pubmed Central, Embase, Google Scholar, CAS, DOAJ, OAIster
Processing time: Decision in 2 weeks for 90% of papers.
Latest news:
Lunasin: A Novel Cancer Preventive Seed Peptide
Blanca Hernández-Ledesma and Ben O. de Lumen
Department of Nutritional Sciences and Toxicology, University of California Berkeley, CA, 94720-3104, U.S.A.
Abstract
Cancer is one of the leading causes of deaths in the Western world. Approximately one-third of these deaths are preventable by lifestyle factors, including modification of nutritional habits. Studies have demonstrated that adequate nutrition with certain types of foods containing bioactive compounds might offer significant protection against carcinogenesis. Soybeans contain a variety of phytochemicals with demonstrated anticancer activity, including isoflavones, protease inhibitors, and more recently lunasin, a novel cancer preventive seed peptide. Initially isolated from soybean, lunasin has also been reported in barley and wheat. The purpose of this review is to summarize the most recent evidence on the possible benefits of lunasin for cancer prevention.
Readers of this also read:
- Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies
- Exploratory Studies on Development of the Chemokine Receptor CXCR4 Antagonists Toward Downsizing
- Small Family with Key Contacts: Par14 and Par17 Parvulin Proteins, Relatives of Pin1, Now Emerge in Biomedical Research
- The Role of Integrins in Cancer and the Development of Anti-Integrin Therapeutic Agents for Cancer Therapy
- Bioactive and Structural Metabolites of Pseudomonas and Burkholderia Species Causal Agents of Cultivated Mushrooms Diseases
- 26/May/2009
Aminoglycosides: Molecular Insights on the Recognition of RNA and Aminoglycoside Mimics
- 28/Apr/2009
Perspectives on Using Physcomitrella Patens as an Alternative Production Platform for Thapsigargin and Other Terpenoid Drug Candidates
- 04/Mar/2009
Bioactive and Structural Metabolites of Pseudomonas and Burkholderia Species Causal Agents of Cultivated Mushrooms Diseases
- 09/May/2008
The Role of Integrins in Cancer and the Development of Anti-Integrin Therapeutic Agents for Cancer Therapy
- 10/Apr/2008
Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies
- 10/Apr/2008
Lunasin: A Novel Cancer Preventive Seed Peptide
- 25/Mar/2008
Effects of FK506 on Ca2+ Release Channels (Review)
- 18/Mar/2008
Small Family with Key Contacts: Par14 and Par17 Parvulin Proteins, Relatives of Pin1, Now Emerge in Biomedical Research
- 07/Mar/2008
Modifications of Antiepileptic Drugs for Improved Tolerability and Efficacy
- 14/Feb/2008
Exploratory Studies on Development of the Chemokine Receptor CXCR4 Antagonists Toward Downsizing
- 10/Feb/2008
The Role of Glucose Metabolism and Glucose-Associated Signalling in Cancer
- 18/Jan/2008
Chemical Chaperone and Inhibitor Discovery: Potential Treatments for Protein Conformational Diseases
- 11/Dec/2007
Derivatives of 5-Aminolevulinic Acid for Photodynamic Therapy
- 11/Dec/2007
The pKa Distribution of Drugs: Application to Drug Discovery
- 17/Sep/2007
FTY720 Story. Its Discovery and the Following Accelerated Development of Sphingosine 1-Phosphate Receptor Agonists as Immunomodulators Based on Reverse Pharmacology
- 06/Sep/2007
Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034
- 26/Jun/2007